Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -8.70% is 95% above its 5-year average of -162.17%, around the middle of its 5-year range (-620.71%–437.49%).
85.09% above its 12-month average of -58.36%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 59.44%.
NET PROFIT MARGIN
-8.70%
NET PROFIT MARGIN AVG TTM
-58.36%
NET PROFIT MARGIN AVG 3Y
-119.33%
NET PROFIT MARGIN AVG 5Y
-162.17%
NET PROFIT MARGIN AVG 10Y
-184.51%
NET PROFIT MARGIN AVG 15Y
-158.58%
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+85.09%
CURRENT VS 3Y AVG
+92.71%
CURRENT VS 5Y AVG
+94.64%
CURRENT VS 10Y AVG
+95.28%
CURRENT VS 15Y AVG
+94.51%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 674 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
MacroGenics, Inc.
Market Cap
$235.50M
Net Profit Margin
-8.70%
TTM Avg
-58.36%
3Y Avg
-119.33%
5Y Avg
-162.17%
Market Cap
$237.00M
Net Profit Margin
-912.25%
TTM Avg
-448.06%
3Y Avg
-224.03%
5Y Avg
-224.03%
Market Cap
$238.36M
Net Profit Margin
-4.52%
TTM Avg
-4.68%
3Y Avg
-9.38%
5Y Avg
-10.81%
Market Cap
$239.72M
Net Profit Margin
-2543.74%
TTM Avg
-5120.97%
3Y Avg
-6084.02%
5Y Avg
-4060.63%
Market Cap
$242.30M
Net Profit Margin
-155582.08%
TTM Avg
-91683.52%
3Y Avg
-62749.43%
5Y Avg
-41832.95%
Market Cap
$242.35M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$228.33M
Net Profit Margin
-26.97%
TTM Avg
-50.02%
3Y Avg
-94.39%
5Y Avg
-87.59%
Market Cap
$243.50M
Net Profit Margin
-13.54%
TTM Avg
-22.79%
3Y Avg
-26.12%
5Y Avg
-61.39%
Market Cap
$243.62M
Net Profit Margin
N/A
TTM Avg
-26.91%
3Y Avg
-35.21%
5Y Avg
-46.29%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MacroGenics, Inc. (MGNX) | $235.50M | -8.70% | -58.36% | -119.33% | -162.17% |
| BioAge Labs Inc. (BIOA)vs › | $237.00M | -912.25% | -448.06% | -224.03% | -224.03% |
| High Tide Inc. (HITI)vs › | $238.36M | -4.52% | -4.68% | -9.38% | -10.81% |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $239.72M | -2543.74% | -5120.97% | -6084.02% | -4060.63% |
| InflaRx N.V. (IFRX)vs › | $242.30M | -155582.08% | -91683.52% | -62749.43% | -41832.95% |
| Galectin Therapeutics Inc. (GALT)vs › | $242.35M | 0.00% | 0.00% | 0.00% | 0.00% |
| Biodesix, Inc. (BDSX)vs › | $228.33M | -26.97% | -50.02% | -94.39% | -87.59% |
| Akebia Therapeutics, Inc. (AKBA)vs › | $243.50M | -13.54% | -22.79% | -26.12% | -61.39% |
| Lifecore Biomedical, Inc. (LFCR)vs › | $243.62M | N/A | -26.91% | -35.21% | -46.29% |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $244.71M | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Margin
-48.7%
Net Profit Margin
-8.7%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 59.44% |
| 2026-03-31 | -177.01% |
| 2025-12-31 | -34.33% |
| 2025-09-30 | 23.09% |
| 2025-06-30 | -162.99% |
| 2025-03-31 | -311.07% |
| 2024-12-31 | -86.98% |
| 2024-09-30 | 50.86% |
| 2024-06-30 | -515.55% |
| 2024-03-31 | -573.26% |
| 2023-12-31 | -429.78% |
| 2023-09-30 | 168.84% |
| 2023-06-30 | 437.49% |
| 2023-03-31 | -155.16% |
| 2022-12-31 | 17.51% |
| 2022-09-30 | -59.46% |
| 2022-06-30 | -158.82% |
| 2022-03-31 | -620.71% |
| 2021-12-31 | -410.14% |
| 2021-09-30 | -337.67% |
| 2021-06-30 | -129.84% |
| 2021-03-31 | -303.73% |
| 2020-12-31 | -3.96% |
| 2020-09-30 | -206.97% |
| 2020-06-30 | -299.85% |
| 2020-03-31 | -344.91% |
| 2019-12-31 | -120.66% |
| 2019-09-30 | -248.17% |
| 2019-06-30 | -318.08% |
| 2019-03-31 | -474.01% |
| 2018-12-31 | -271.38% |
| 2018-09-30 | -165.05% |
| 2018-06-30 | -233.10% |
| 2018-03-31 | -1100.56% |
| 2017-12-31 | 68.52% |
| 2017-09-30 | -4372.03% |
| 2017-06-30 | -3760.78% |
| 2017-03-31 | -2946.40% |
| 2016-12-31 | -367.06% |
| 2016-09-30 | -1680.54% |
| 2016-06-30 | 51.55% |
| 2016-03-31 | -1603.96% |
| 2015-12-31 | -302.35% |
| 2015-09-30 | -105.18% |
| 2015-06-30 | -381.85% |
| 2015-03-31 | 63.41% |
| 2014-12-31 | -353.63% |
| 2014-09-30 | -21.48% |
| 2014-06-30 | -133.22% |
| 2014-03-31 | -21.58% |
| 2013-12-31 | -21.75% |
| 2013-09-30 | 32.84% |
| 2013-06-30 | -2.48% |
| 2013-03-31 | -33.44% |
| 2012-12-31 | -22.48% |
| 2012-09-30 | 16.74% |
